On the Verge of Full FDA Approval, New Details About Leqembi Death
In June, the Food and Drug Administration will decide whether to grant full approval to Biogen and Eisai’s anti-amyloid Alzheimer’s drug Leqembi (generic name…
In June, the Food and Drug Administration will decide whether to grant full approval to Biogen and Eisai’s anti-amyloid Alzheimer’s drug Leqembi (generic name…
Without good sleep, getting through the day is a challenge — especially in stressful times. Beyond the day-to-day, unrestful sleep is linked to hypertension,…
Over 30 million people live with Alzheimer’s disease worldwide, making it the most common form of dementia. Two thirds of those diagnoses are women….
As Julie Fleming’s father slipped into the later stages of Alzheimer’s dementia, she could only watch as his computer skills and interests faded. “The…
Like Kanye West, coconut oil has recently undergone a 180° change in its public perception. Coconut oil is a saturated fat meaning that it…
After coming down with the flu during the 1918 influenza pandemic, more than one million people developed a virus-induced form of Parkinson’s disease, with…
A 19-year-old man from China, who has been having memory problems since the age of 17, was diagnosed with dementia, according to a recent…
Caregiver burnout is real. For caregivers of loved ones with dementia, having a support system is crucial, especially due to the amount of stress…
As many as one in three people with Alzheimer’s disease experience hallucinations: They see, hear, smell or otherwise sense things that aren’t actually there….
While other cognitive functions and memories fade away with dementia, musical memories are last to go. Music transports patients to a comfortable moment in…
Would you take a supplement — for example, brain health supplement Neuriva Plus — that claims to boosts your brain function? After all, Mayim…
Many people think of virtual and augmented reality as popular forms of entertainment — but these technologies are becoming more central to healthcare, now…
Brain supplements that claim to boost cognitive function are increasingly popular, growing from a $4 billion industry of about 4,000 unique products to a…
Inflammation is a hallmark of neurodegenerative diseases including multiple sclerosis (MS) and Alzheimer’s disease. The amyloid hypothesis still dominates in the conversation about what…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. “I was driving home from work and…